Problem Management Plus With Emotional Processing (PM+EP) for Forcibly Displaced Youth
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-25
SponsorKarolinska Institutet
About this trial
The goal of this feasibility randomized controlled trial is to learn about the feasibility and acceptability of scalable psychological interventions in Sweden. It will also allow for a preliminary exploration of a novel modular addition targeting traumatic stress to Problem Management Plus (PM+), an evidence-based transdiagnostic psychological intervention for psychological distress.
The main question it aims to answer is whether PM+ and PM+ Emotion Processing (PM+EP) feasible and acceptable among forcibly displaced youth in Sweden?
Participants will be randomized to receive PM+, PM+EP, or treatment as usual. The two intervention arms consist of a weekly session for six weeks.
Assessments will collect data on a variety of psychological symptoms, wellbeing, and service use throughout the duration of the study. Assessments will take place at baseline, 1-week post-intervention, and 3-weeks post-intervention.
Eligibility criteria
Qualifiers
16 to 25 year old youth who arrived in Sweden in 2015 or later due to being forcibly displaced;
Elevated levels of psychological distress as determined through the Kessler-10 psychological distress scale (K10; K10 > 15);
Reduced levels of psychosocial functioning as measured by the WHO Disability Assessment Schedule (WHODAS 2.0; WHODAS 2.0 > 16);
Assessment and manual are available in their preferred language, including Swedish.
Disqualifiers
An acute medical condition;
Imminent suicide risk;
Indication of psychotic disorders and substance-dependence;
Indication of severe cognitive or neurological impairment;
Trial design
Treatments tested in this trial
- Problem Management Plus (PM+)
- Problem Management Plus with Emotional Processing Module (PM+EP)
- Care as usual
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Karolinska Institutet
Lead sponsor
Rädda Barnen
Collaborator
Source ClinicalTrials.gov